LINC00701

Across TCGA pan-cancer cohorts, LINC00701 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated LINC00701 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher LINC00701 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00701 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

CHOL, LIHC, and KIRC are the cancer types where LINC00701 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.728	<.001	108	view →
LIHC	OS	Tertile	II,III,IV	0.040	0.720	<.001	99	view →
KIRC	DFS	Tertile	II,III,IV	0.155	0.663	.001	48	view →
COAD	DFS	Tertile	All	0.350	0.539	.012	39	view →
READ	DFS	Tertile	IV	0.339	0.691	<.001	27	view →
UCEC	OS	Tertile	All	0.300	0.708	<.001	24	view →
LAML	DFS	Tertile	All	0.138	0.440	.009	18	view →
KIRP	DFS	Tertile	All	0.699	0.875	.015	6	view →
LUSC	OS	Quartile	All	0.846	0.733	.014	5	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

LINC00701–CHOL (OS)

Open the CHOL breakdown →